In Chronic Leukemias and Lymphomas: Clinical Management, a panel of recognized experts in hematological oncology describe the unique biological features of indolent hematologic neoplasms, providing powerful insight into their clinical manifestation, highlighting potential targets for novel therapies, and distinguishing these disorders from aggressive lymphoma and Hodgkin's disease. In their integrated surveys of these chronic myeloproliferative and lymphoproliferative disorders, the authors emphasize such unique entities as prolymphocytic leukemias and cutaneous lymphomas. Special emphasis is given to the mechanisms of disease progression with authoritative insights into the promising new era of antineoplastic pharmacology.
Indice testuale
Chronic Leukemias: History, Epidemiology, and Risk Factors Kanti R. Rai and Niraj Gupta Chronic Lymphocytic Leukemia: Diagnosis and Management Jamie D. Cavenagh and T. Andrew Lister Hairy Cell Leukemia: Biology, Diagnosis, and Treatment Nicole Wentworth and Alan Saven Prolymphocytic Leukemias Peter J. Rosen and Jonathan Said Chronic Myeloid Leukemia Neil P. Shah and Charles L. Sawyers Sezary Syndrome: The Redefinition of a Clinico-Pathologic Entity and its Implication for Staging, Prognosis, and Treatment Lauren C. Pinter-Brown Large Granular Lymphocyte Proliferative Diseases Mustafa Benekli and Maria R. Baer Myeloproliferative Syndromes Nelida N. Sjak-Shie and Gary J. Schiller Advances in the Biology and Treatment of Multiple Myeloma James R. Berenson and Robert A. Vescio Low-Grade Lymphoma Christos Emmanouilides Aggressive Large-Cell Lymphomas R. Gregory Bociek and James O. Armitage Hodgkin's Disease Steven M. Horwitz and Sandra J. Horning Index
